Epicrispr Biotechnologies

Epicrispr Biotechnologies

Founded in 2018, Epicrispr Biotechnologies is building the world’s leading platform for precision genetic regulation to address serious diseases with little to no available treatments. Our GEMS (Gene Expression Modulation System) platform enables the design of medicines that flexibly, precisely and reversibly modify gene expression, a potential that drug developers have long sought to achieve but which today’s approaches fall short of accomplishing.

We are based on the science of our founder, Stanley Qi, one of the co-inventors of the original Nobel Prize-winning CRISPR patents and is a recognized global leader in the field of genetic regulation using the CRISPR-Cas architecture. Dr. Qi furthered the technology so that DNA does not need to be cut to accomplish precise gene regulation. 

So, if joining a high-performing, incredibly fun, and creative team sounds like something you'd love, take a look through our current openings. We're always looking for amazing talent and we'd love to chat. 

Open roles
7
live now
New today
0
last 24 hours
Worldwide remote
0
from anywhere
Departments
4
hiring across

Catch your next role the second it’s posted.

Create a free account and we’ll watch the boards for you — the instant a job matches your search, it lands in your inbox or Telegram. No digging, no refreshing.

Create free account

Free forever · takes 30 seconds · already have one?

Get an edge on your job hunt.

Join our Telegram channel for the stuff that helps you land the role — salary benchmarks, the weekly market pulse, and new-feature drops. No spam, just signal.

Join the channel — it's free